Modified PHI29 DNA polymerases and uses thereof
Disclosed herein, inter alia, are mutant enzymes, kits, and methods of use thereof.
1. A polymerase comprising an amino acid sequence that is at least 85% identical to SEQ ID NO: 1; comprising a proline, tryptophan, phenylalanine, tyrosine, alanine, or glycine at an amino acid position corresponding to position 216 of SEQ ID NO:1.
2. The polymerase of claim 1 , comprising a proline at amino acid position corresponding to position 216.
3. A polymerase comprising an amino acid sequence that is at least 85% identical to SEQ ID NO: 1; comprising an amino acid substitution, wherein said amino acid substitution comprises: D34E, F47I, P87S, I93N, I119V, K131E, K132E, K135E, I179F, S192C, F198L, T203S, L216P, D219N, T231I, E239G, S260N, K311R, A324T, Y343C, K366R, I378V, L381Q, A394V, G401V, G417R, W436R, A444V, A447T, L462I, H485L, E486V, S487C, Y500F, K536E, K539E, R552Q, V565M, L567M, S578G, or G579S.
4. A method of incorporating a nucleotide into a nucleic acid sequence comprising combining in a reaction vessel: (i) a nucleic acid template, (ii) a nucleotide solution comprising a plurality of nucleotides, and (iii) a polymerase, wherein the polymerase is the polymerase of claim 1 .
5. A method of amplifying a nucleic acid sequence, said method comprising:
a) hybridizing a nucleic acid template to a primer to form a primer-template hybridization complex;
b) contacting said primer-template hybridization complex with a polymerase and a plurality of nucleotides, wherein the polymerase is the polymerase of claim 1 ;
c) subjecting the primer-template hybridization complex to conditions which enable the polymerase to incorporate one or more nucleotides into the primer-template hybridization complex to generate amplification products, thereby amplifying a nucleic acid sequence.
6. A method of amplifying a template polynucleotide, the method comprising: contacting a template polynucleotide with an amplification primer, and amplifying the template polynucleotide by extending an amplification primer with a polymerase to generate an extension product comprising one or more complements of the template polynucleotide; wherein said polymerase is a polymerase of claim 1 .
7. The method of claim 6 , comprising amplifying the template polynucleotide in a cell.
8. The method of claim 6 , comprising amplifying the template polynucleotide in a tissue.
9. The method of claim 6 , wherein said amplification primer is immobilized on a solid support.
10. A method of incorporating a nucleotide into a nucleic acid sequence comprising combining in a reaction vessel: (i) a nucleic acid template, (ii) a nucleotide solution comprising a plurality of nucleotides, and (iii) a polymerase, wherein the polymerase is a polymerase of claim 3 .
11. A method of amplifying a nucleic acid sequence, said method comprising:
a) hybridizing a nucleic acid template to a primer to form a primer-template hybridization complex;
b) contacting said primer-template hybridization complex with a DNA polymerase and a plurality of nucleotides, wherein the DNA polymerase is the polymerase of claim 3 ;
c) subjecting the primer-template hybridization complex to conditions which enable the polymerase to incorporate one or more nucleotides into the primer-template hybridization complex to generate amplification products, thereby amplifying a nucleic acid sequence.
12. A method of amplifying a template polynucleotide, the method comprising: contacting a template polynucleotide with an amplification primer, and amplifying the template polynucleotide by extending an amplification primer with a polymerase to generate an extension product comprising one or more complements of the template polynucleotide; wherein said polymerase is a polymerase of claim 3 .
13. The method of claim 12 , comprising amplifying the template polynucleotide in a cell.
14. The method of claim 12 , comprising amplifying the template polynucleotide in a tissue.
15. The method of claim 12 , wherein said amplification primer is immobilized on a solid support.
16. The polymerase of claim 1 , further comprising a glutamic acid, aspartic acid, alanine, glycine, or threonine at an amino acid position corresponding to position 131 of SEQ ID NO:1.
17. The polymerase of claim 1 , further comprising a glutamic acid, aspartic acid, alanine, glycine, or threonine at an amino acid position corresponding to position 132 of SEQ ID NO:1.
18. The polymerase of claim 1 , further comprising a glutamic acid, aspartic acid, alanine, glycine, or threonine at an amino acid position corresponding to position 536 of SEQ ID NO:1.
19. The polymerase of claim 1 , further comprising a glutamic acid, aspartic acid, alanine, or glycine at the amino acid position corresponding to position 135; and a glutamic acid, aspartic acid, alanine, glycine, or threonine at the amino acid position corresponding to position 536.
20. The polymerase of claim 1 , comprising the amino acid substitutions:
a) K131E, K135E, L216P, and K536E;
b) K132E, K135E, L216P, and K536E;
c) K135E, L216P, and K536E;
d) L216P and T231I;
e) K135E, L216P, K536E, and K538E;
f) K131E, K135E, L216P, K536E, and K539E;
g) K135E, L216P, K536E, and K539E;
h) K135E, L216P, K536E, K538E, and K539E;
i) K135E and L216P;
j) K132E, K135E, L216P, K536E, and K539E;
k) M8I, T203S, and L216P; or
l) K131E, K132E, K135E, L216P, and K536E.